Rapigen Secures WHO Prequalification for Three pLDH-Based Malaria Rapid Diagnostic Tests
NY, UNITED STATES, April 24, 2026 /EINPresswire.com/ -- pLDH-Based Diagnostic Technology Addresses Growing Threat of HRP2 Gene Deletions — Enabling Expanded Access to Global Malaria Diagnostics Markets Rapigen, Inc., an in vitro diagnostics …